ALSO NOTED: Xenova agrees to buyout; Genentech boosting manufacturing; Pfizer expands research lab; and much more...

> UK-based Xenova has agreed to be acquired by the newly formed Celtic Group. Story

> Expecting to see a big demand for its therapies, Genentech is boosting its manufacturing abilities to nearly full capacity. Article

> Pfizer is expanding its research lab in Cambridge, Massachusetts. Story

> Pfizer is also planning a $5 billion stock buyback. Story

> ODC Therapy has received the OK to expand clinical trials into a cancer vaccine. Report

And Finally... The Rehabilitation Institute of Chicago is developing a prosthetic limb that restores a sense of touch. Story

Suggested Articles

The company, which was co-founded by Jim Mellon, has reeled in $165 million in 18 months to establish itself at the forefront of the longevity field.

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.